This trial will test whether qigong, a mind and body approach that incorporates gentle body movements, paired with a focus on breathing and body awareness to promote health and wellness, can reduce SCI-related neuropathic pain.
- Spinal Cord Injury
1 Primary · 7 Secondary · Reporting Duration: 24 weeks
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
64 Total Participants · 2 Treatment Groups
Primary Treatment: Qigong · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 75 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||100.0%|
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Frequently Asked Questions
What is the extent of participant involvement in this experiment?
"Correct. Information hosted on clinicaltrials.gov suggests that this medical investigation, which was initially advertised on July 1st 2021, is actively enrolling people in its experiment. Approximately 64 subjects need to be recruited from a single site." - Anonymous Online Contributor
Are there any available openings for participants in this research?
"Affirmative. According to clinicaltrials.gov, this trial is presently looking for participants with the first posting date on July 1st 2021 and most recent edit on August 30th 2022. This medical experiment requires 64 people from a single site to join in its research efforts." - Anonymous Online Contributor
What demographic of individuals is eligible to participate in this clinical investigation?
"This trial is recruiting for 64 individuals who have sustained a spinal cord injury and are between the ages of 18-75. Most importantly, participants must report an intensity of greater than 3 on the numeric pain rating scale in relation to their SCI-related neuropathic pain." - Anonymous Online Contributor
Does this medical experiment welcome geriatric participants?
"The age range for those wishing to join this trial is 18-75. For younger and older participants, there are 145 clinical trials available targeting minors and 863 studies accommodating seniors respectively." - Anonymous Online Contributor